Flinders University, Adelaide, Australia.
Flinders Centre for Innovation in Cancer, Adelaide, Australia.
Psychooncology. 2019 Jul;28(7):1506-1512. doi: 10.1002/pon.5107. Epub 2019 Jun 6.
Distress in patients with cancer is a significant problem that affects up to 32% of patients. Yet research indicates that 35% of cancer patients do maintain high levels of well-being. Resilience is one psychological factor implicated as being protective against distress; however, the mechanisms for this relationship are currently unknown. The present study aimed to explore emotion regulation as a potential mediator of the relationship between resilience and distress.
A cross-sectional survey examining emotional regulation, resilience, and distress was completed by 227 patients from two hospitals with heterogeneous cancer types. Measures included the Difficulties in Emotion Regulation Scale (DERS), the Connor Davidson Resilience Scale, and the Depression, Anxiety, Stress Scale.
Difficulties in emotion regulation and resilience explained 33.2% of the variance in distress. Resilience had a significant direct effect on distress, accounting for 15.8% of the variance. However, this effect was no longer significant when difficulties in emotion regulation were controlled for. The indirect effect through difficulties in emotion regulation was significant, b = 0.009, 95% CI [-0.013,-0.007], suggesting that the effect of resilience on distress was fully mediated by emotion regulation. Parallel mediation analyses also examined the differential effects of the six DERS subscales on the relationship between resilience and distress.
These findings suggest that emotion regulation is an important mediator of resilience in cancer. Hence, in patients with cancer, difficulties in emotion regulation (and the DERS specifically) might be a useful focus for screening for patients at risk of distress.
癌症患者的痛苦是一个严重的问题,影响了多达 32%的患者。然而,研究表明,35%的癌症患者保持着较高的幸福感。韧性是一种被认为可以预防痛苦的心理因素;然而,这种关系的机制目前尚不清楚。本研究旨在探讨情绪调节作为韧性与痛苦之间关系的潜在中介。
本研究采用横断面调查,对来自两家癌症类型不同的医院的 227 名患者进行了情绪调节、韧性和痛苦的评估。测量工具包括困难情绪调节量表(DERS)、Connor-Davidson 韧性量表和抑郁、焦虑、压力量表。
情绪调节困难和韧性解释了痛苦的 33.2%的方差。韧性对痛苦有显著的直接影响,占方差的 15.8%。然而,当控制情绪调节困难时,这种影响就不再显著了。通过情绪调节困难的间接效应是显著的,b=0.009,95%CI[-0.013,-0.007],这表明韧性对痛苦的影响完全被情绪调节所中介。平行中介分析还检验了 DERS 的六个子量表对韧性和痛苦之间关系的差异影响。
这些发现表明,情绪调节是癌症中韧性的一个重要中介。因此,在癌症患者中,情绪调节困难(特别是 DERS)可能是筛查有痛苦风险的患者的一个有用的焦点。